StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA 510(k) Device Clearances — Total U.S. MedTech Industry

U.S. FDA openFDA 510(k) Database

QuarterlyAnnualMonthly
Latest, Q3 2026
855
Period ended Sep 30, 2026
Change on a year earlier
+7.3%
797 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA 510(k) Device Clearances — Total U.S. MedTech IndustryYear on yearSource
Q3 2026Sep 30, 2026855+7.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2026Jun 30, 2026923+4.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2026Mar 31, 2026756+2.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2025Dec 31, 2025806-5.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2025Sep 30, 2025797+3.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2025Jun 30, 2025886+11.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2025Mar 31, 2025736+3.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2024Dec 31, 2024856-2.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2024Sep 30, 2024767-13.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2024Jun 30, 2024793-2.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2024Mar 31, 2024713-8.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2023Dec 31, 2023877+2.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2023Sep 30, 2023883+11.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2023Jun 30, 2023809-2.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2023Mar 31, 2023777+6.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2022Dec 31, 2022857+6.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA 510(k) Device Clearances — Total U.S. MedTech Industry, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-510k-ind

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.